– Testing aimed at increasing clinical confidence among medical professionals through objective data –
SCOTTSDALE, Ariz., July 26, 2024 (SEND2PRESS NEWSWIRE) — Personal Practitioners today announced the adoption of QbTest, an objective ADHD test that provides clinicians with measurable data for unbiased decision-making and support. Developed by Qbtech, a global leader in ADHD testing, the test is the first FDA-cleared solution to aid clinicians in diagnosing and treating ADHD in children, adolescents and adults.
Qbtech offers both in-clinic and telehealth testing capabilities, performed in partnership with healthcare providers. QBTest uses a highly accurate infrared motion tracking system to measure motor activity down to the millimeter in a 15-20 minute computer-based test. Results are instantly analyzed and presented as a report comparing the patient’s results to a group of people of the same age and gender at birth who do not have ADHD.
“We are pleased to introduce this innovative technology to help clinicians better understand the core symptoms of ADHD,” said Rebecca Blakeslee, Practice Director at Personal Practitioners. “QbTest provides an opportunity to improve care models for patients suffering from ADHD by providing objective, tangible results for a more comprehensive ADHD assessment and treatment management program.”
QbTest data provides clinicians with additional insight into treatment effectiveness, enabling patients to access customized treatments faster and improving patient outcomes.
“Qbtech prides itself on providing clinicians with industry-leading technology to treat their patients,” said Tony Doyle, commercial director at Qbtech. “ADHD plays a key role in the current mental health crisis and incorporating objective data into standard care is essential to treating patients effectively and efficiently.”
Personal Practitioners joins a growing list of approximately 10,000 clinicians worldwide who employ objective measures to more accurately diagnose or rule out ADHD in their patients. Qbtech has performed over 600,000 tests, with 120,000 of those performed via telehealth. QBTest is available for appointment scheduling for both new and existing patients. To learn more, visit https://www.personalpractitioners.com/adhd-evaluations-qbtech.
About Qbtech:
Founded in 2002, Qbtech is a privately held Swedish company that has developed cutting-edge solutions and products to improve the diagnosis, treatment and follow-up of people with ADHD. Qbtech operates in 13 countries with offices in Stockholm, Houston and London. Qbtech is an award-winning company recognized for innovation, most recently winning the 2022 HSJ Partnership Award for “Best Mental Health Partnership with the NHS.” For more information, please visit https://www.qbtech.com/.
About our Personal Practitioners:
Personal Practitioners is a locally-owned mental health clinic based in Scottsdale, Arizona, providing personalized, comprehensive mental health care through office visits and telehealth. Personal Practitioners’ practice philosophy embraces a holistic, science-based, technology-first approach to psychiatry. Partnerships with leading innovators in patient diagnostic solutions are an integral part of the clinic’s commitment to providing the highest standard of patient-centered care tailored to the unique, individual needs of each patient. For more information, please visit https://www.personalpractitioners.com/.
Media Contact:
Rebecca Blakeslee
rebecca@personalpractitioners.com
602-800-4699
News source: Private Practice
Keywords: Mental Health & Psychology, Private Practice AZ, ADHD Testing, QbTest, Telehealth, Healthcare, Psychology, Education, Counseling, Scottsdale, AZ.
This press release has been issued by Send2Press® Newswire on behalf of the news source (Personal Practitioners), who are solely responsible for its accuracy. Information is believed to be accurate but is not guaranteed. Story ID: 119968 APDF15TBLLI
To view the original version, visit https://www.send2press.com/wire/personal-practitioners-az-announces-use-of-objective-adhd-testing-technology-for-diagnosis-and-treatment/
© 2024 Send2Press® Newswire, a press release distribution service, California, USA.
Disclaimer: The content of this press release was not created or published by The Associated Press. The following content is independent of this news story.
Copyright 2024 Send2Press Newswire
